histograms and the curve with non-linear regression Search Results


90
GraphPad Software Inc binding-saturation-one site-specific binding model
Binding Saturation One Site Specific Binding Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/binding-saturation-one site-specific binding model/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
binding-saturation-one site-specific binding model - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc concentration-response curve fit to the nonlinear regression model using graphpad prism® v6.0 software
Concentration Response Curve Fit To The Nonlinear Regression Model Using Graphpad Prism® V6.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/concentration-response curve fit to the nonlinear regression model using graphpad prism® v6.0 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
concentration-response curve fit to the nonlinear regression model using graphpad prism® v6.0 software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc curve-fitting of the four-parameter nonlinear-logistic-regression model graphpad prism
Curve Fitting Of The Four Parameter Nonlinear Logistic Regression Model Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/curve-fitting of the four-parameter nonlinear-logistic-regression model graphpad prism/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
curve-fitting of the four-parameter nonlinear-logistic-regression model graphpad prism - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
OriginLab corp linear and non-linear regression curve fitting originw 7.03
Linear And Non Linear Regression Curve Fitting Originw 7.03, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/linear and non-linear regression curve fitting originw 7.03/product/OriginLab corp
Average 90 stars, based on 1 article reviews
linear and non-linear regression curve fitting originw 7.03 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression curve fit with a variable slope and graphpad prism 4.0 software
Nonlinear Regression Curve Fit With A Variable Slope And Graphpad Prism 4.0 Software, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression curve fit with a variable slope and graphpad prism 4.0 software/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression curve fit with a variable slope and graphpad prism 4.0 software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear regression one-site and two-site binding models derived from the cheng-prusoff equation graphpad prism version 5.0
Non Linear Regression One Site And Two Site Binding Models Derived From The Cheng Prusoff Equation Graphpad Prism Version 5.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear regression one-site and two-site binding models derived from the cheng-prusoff equation graphpad prism version 5.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear regression one-site and two-site binding models derived from the cheng-prusoff equation graphpad prism version 5.0 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression (curve fit) program based on the one phase decay graphpad prism 9.4
Nonlinear Regression (Curve Fit) Program Based On The One Phase Decay Graphpad Prism 9.4, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression (curve fit) program based on the one phase decay graphpad prism 9.4/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression (curve fit) program based on the one phase decay graphpad prism 9.4 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc xy analysis for nonlinear regression curve and the 3-parameters dose-response stimulation function
Xy Analysis For Nonlinear Regression Curve And The 3 Parameters Dose Response Stimulation Function, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xy analysis for nonlinear regression curve and the 3-parameters dose-response stimulation function/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
xy analysis for nonlinear regression curve and the 3-parameters dose-response stimulation function - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc global nonlinear regression analysis of the dose–response curves
Global Nonlinear Regression Analysis Of The Dose–Response Curves, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/global nonlinear regression analysis of the dose–response curves/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
global nonlinear regression analysis of the dose–response curves - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression curves and 80% neutralization titers (nt80)
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Nonlinear Regression Curves And 80% Neutralization Titers (Nt80), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression curves and 80% neutralization titers (nt80)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression curves and 80% neutralization titers (nt80) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc log concentration—inhibition curves
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Log Concentration—Inhibition Curves, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/log concentration—inhibition curves/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
log concentration—inhibition curves - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc nonlinear regression curve for the normalised response (variable slope)
a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and <t>neutralization</t> assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers <t>(NT80)</t> plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.
Nonlinear Regression Curve For The Normalised Response (Variable Slope), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear regression curve for the normalised response (variable slope)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
nonlinear regression curve for the normalised response (variable slope) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and neutralization assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers (NT80) plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.

Journal: Nature Communications

Article Title: SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

doi: 10.1038/s41467-020-18468-8

Figure Lengend Snippet: a IgG S/C ratios were determined for hospitalized patients and outpatients and blood donors on whom SARS-CoV-2 PCR testing was positive or negative or was not performed. Numbers of seroreactive and total individuals tested are shown in tables below the graphs. The circled data points were additionally tested by the VITROS and neutralization assays and were negative by both assays. For patients with multiple samples, the single highest S/C value is plotted. b IgM S/C ratios, as in a . c (Left) IgG and IgM titers for SARS-CoV-2 PCR positive matched patient samples. Percent of data points in each quadrant and positive percent agreement (PPA), negative percent agreement (NPA), and overall percent agreement (OPA) between IgG and IgM are shown. (middle) 80% neutralization titers (NT80) plotted against IgG S/C values. (right) 80% NT80 plotted against IgM S/C values. The cutoff for NT80 is a titer level of >40; negative results (<40) are non-numeric and are plotted at 35 for visualization purposes. d NT80 titers for SARS-CoV-2 PCR-positive patients were plotted against day post symptom onset. Immunocompromised patients are shown in blue. e For the 6 SARS-CoV-2 PCR-positive patients whose IgM, IgG, and NT80 seroconversion events were captured during serial sampling, the days post-symptom onset seroconversion events are compared. f NT80 activity was evaluated per patient for the indicated time frames post onset of symptoms. The percent of patients with detectable NT80 activity measured within each time frame is indicated below the graphs. If multiple samples per patient were collected, the sample with the highest NT80 value within each time frame was used. g The average NT80 activity (right axis) and IgG and IgM (left axis) titers are plotted by day post-symptom onset (left); corresponding graphs for individual patients are shown in a 3 × 3 grid (right). If multiple samples per patient were collected, the sample with the highest S/C or NT80 value per time frame was used. For f , the box outlines denote the IQR, the solid line in the box denotes median neutralizing antibody titer, and the whiskers outside of the box extend to the minimum and maximum neutralizing antibody titers.

Article Snippet: Nonlinear regression curves and 80% neutralization titers (NT80) were calculated in GraphPad Prism v8.

Techniques: Neutralization, Sampling, Activity Assay